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Abstract
Neuropathy is one of the most common and costly complication of diabetes, being unnoticed in
50% of the patients with this condition. Gait analysis of diabetic patients with peripheral neu-
ropathy has received interest by the authors since the alteration of walking patterns is a common
characteristic of this disease.
In this project, a study was made regarding the necessity to identify early signs of diabetic
neuropathy by the analysis of walking patterns.
With reference on previous studies, plantar pressure sensors and smartphones built-in ac-
celerometers were used to collect gait data. After data collection, features were extracted and
selected from signals, which allowed the training of a classifiers to learn, based on these metrics,
how to differentiate the different groups of interest. In order to evaluate differences in terms of
performance, two classifiers were tested - k-Nearest Neighbours and Support Vector Machine.
Two datasets were analysed - dataset 1 and dataset 2. Ideally, it would be necessary use both
accelerometers and plantar pressure sensors to collect data from healthy subjects, diabetic patients
without peripheral neuropahty, and diabetic patients with peripheral neuropathy. However, none
of the analysed datasets met all these desirable requirements.
In dataset 1, features were extracted only from plantar pressure sensors and two tests were
performed - conditioned and free tests. The more accurate results were obtained when the subject
walked freely, without the examination of any physician/doctor. Additionally, the best perfor-
mances achieved, in dataset 1, to identify the presence of diabetes and neuropathy were 80.50%
and 90% , respectively.
In dataset 2, data was collected with both accelerometers and plantar pressure sensor. How-
ever, none of the diabetes patients were diagnosed with neuropathy. As a results, the diabetes
patients were split based on disease durations - lower ans higher than 20 years. This division was
chosen since the prevalence of neuropathy increases with the duration of diabetes. Hereupon, it
is expected that the results obtained from this division are similar to the ones encountered if the
presence of neuropathy was tested. Moreover, in dataset 2, the best accuracy of classifications was
96% for both classification (identify the presence of diabetes and differentiate disease duration).
The performances obtained, in dataset 2, were higher than in dataset 1, suggesting that the
both use of plantar pressure sensors and accelerometer data is important to characterize the gait
of diabetes and identify the presence of diabetic neuropathy. However, the dimension of dataset 2
was small. Consequently, additional validation on a larger number of subjects is need.
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Finally, statistical analysis suggested that diabetes and the increased disease duration could
lead to a non-gradual and imbalance plantar pressure distribution.
Keywords:Diabetes, Diabetic Neuropathy, Plantar Pressure Sensors, Accelerometer Data,
Machine Learning
Resumo
A neuropatia é uma das condições mais comum e dispendiosa da diabetes, passando despercebida
em cerca de 50% dos pacientes com esta condição. A análise da marcha de pacientes diabéticos
com neuropatia tem despoletado bastante interesse uma vez que, normalmente, esta doença leva à
alteração dos padrões de marcha.
Neste projecto, for realizado um estudo sobre a necessidade de identificar sinais relacionados
com a neuropatia diabética, através da análise de padrões de marcha.
Com referência em estudos anteriores, foram utilizados sensores de pressão plantar e aceleromet-
ros para recolher dados de marcha de individuos saudáveis e diabéticos. Seguidamente, foram
extraídas e seleccionadas características específicas, o que permitiu a utilização de classificadores
que, com bases nestas métricas, diferenciaram diferentes grupos de interesse. Com o objectivo de
avaliar e comparar a performance de diferentes classificadores, dois classificadores foram aplica-
dos - k-Nearest Neighbours and Support Vector Machine.
Para estes efeitos, foram avaliadas duas bases de dados, Base de Dados 1 e Base de Dados 2.
Idealmente, os dados constituintes das duas base de dados deveriam englobar a recolha de sinais
de marcha a individuos saudáveis e diabéticos - com e sem neuropatia -, recorrendo a sensores
de pressão plantar e acelerómetros. No entanto, nenhuma das bases de dados analisadas cumpriu
todos estes requisitos.
Na Base de Dados 1, os dados foram recolhidos apenas recorrendo a sensores de pressão
plantares e em duas situações diferentes de marcha: teste condicionado e teste livre. Os resultados
mais precisos foram obtidos aquando do teste livre, onde o participante realizava uma marcha
livre de examinação de um médico e sem uma rota definida. O melhor desempenho obtido pelos
classificadores na identificação de presença de diabetes e identificação da presença de diabetes e
neuropatia foi de 80,50% e 90%, respetivamente.
Na Base de Dados 2, os dados foram recolhidos através de sensores de pressão plantar e
acelerómetros. No entanto, nenhum individuo com diabetes e cujo padrão de marcha foi recolhido,
padecia diabetes neuropatia. Para ultrapassar esta limitação, os dados foram subdivididos tendo
como base a duração da doença - inferior e superior a 20 anos. Este processamento de dados foi
escolhida uma vez que a prevalência da neuropatia aumenta com a duração da diabetes. Assim
sendo, é esperado que os resultados obtidos com esta divisão sejam semelhantes aos que seriam
encontrados se a indentificação de estados de neuropatia tivesse sido avaliada. Com os sinais de
marcha desta base de dados, o melhor desempenho obtido pelos classificadores na identificação
da presença de diabetes e na diferenciação da duração da doença foi de 96%, para ambas as
classificações.
Os desempenhos obtidos na Base de Dados 2 foram superiores, sugerindo que o uso com-
binado de sensores de pressão plantar e acelerómeteros é importante para caracterizar a marcha
de diabéticos e identificar a presença da neuropatia. No entanto, é importante mencionar que a
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dimensão da Base de Dados 2 foi inferior à da Base de Dados 1. Consequentemente, é necessária
uma validação destes resultados com uma base de dados de igual ou maior dimensão que a 2.
Finalmente, a análise estatística sugeriu que tanto a diabetes como o aumento da duração da
doença pode causar não só uma distribuição nao gradual das pressões plantares, mas também um
desiquilíbrio nessa mesma distribuição.
Keywords: Diabetes. Neuropatia. Sensores de pressão plantar. Acelerómetros. Machine
Learning.
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Chapter 1
Introduction
Analysis of human gait begun in the 19th century, being at the present time subject of many re-
search projects [1]. This type of analysis has been centered on achieving quantitative objective
measurement of different parameters that characterize gait in order to apply them to various fields
such as identification of people for security purposes and medicine [1].
In the medical field, accurate reliable knowledge of gait characteristics at a given time, and
even more importantly, monitoring and evaluating them over time, will enable early diagnosis of
diseases, prevention of their complication and help to find the best treatment [1]. Therefore, gait
analysis has special interest when searching for decisive information on the evolution of different
diseases, namely [1]:
• Neurological diseases such as multiple sclerosis or Parkinson’s
• Systemic diseases such as cardiopathies
• Alterations in deambulation dynamic due to sequelae from stroke
• Diseases caused by ageing, which affect a large percentage of the population
• Diabetes
This first chapter will focus on the main motivations and objectives for the development of this
thesis as well as summarizes the main steps of this study. A structure of the dissertation is also
presented.
1.1 Motivation and Objectives
Neuropathy is a common and costly complication of diabetes, being the leading cause of non-
traumatic limb amputations [2]. There is increasing evidence that even pre-diabetic conditions are
also associated with some forms of neuropathy.
In some cases, diabetic neuropathy may be unnoticed, since up to 50% of the patients with this
condition have no symptoms [3]. Therefore, the motivation behind this project is the identification
of early signs that allow the discrimination of diabetic neuropathy stages.
1
2 Introduction
Several studies have analysed gait characteristics of diabetic neuropathy patients, suggesting
that this disease significantly alters the walking patterns of the patients.
The aim of this work was to devise a methodology able to identify the presence of diabetic neu-
ropathy through gait analysis. The data was collected using smartphones built-in accelerometers
and plantar pressure sensors (Walkinsense system).
Initially, preliminary tests were performed in order to evaluate the methodology and the best
experimental protocol to achieve the aim of this study.
Afterwards, two datasets were tested:
• Dataset 1 - collected by Oliveira and Correia in the study "Evaluation Gait Cycle and Plantar
pressure in Diabetic Patients with Walkinsense" [4].
• Dataset 2 - collect at Fraunhofer AICOS installations, with elderly volunteers.
After data acquisition, the data was processed and a machine learning methodology was ap-
plied in order to identify gait patterns. Additionally, it was studied suitable features and classifiers
with the highest performance.
1.2 Structure of the Dissertation
Apart from this Introduction, this dissertation consists of six chapters. Chapter 2 is a literature
review focused on the diabetic peripheral neuropathy and the alterations associated with this dis-
ease. In chapter 3, the devices and methodology implemented are present. In Chapter 4, prelimi-
nary tests are described and evaluated. In Chapter 5, the implemented methodology is described,
in detail, and its results and discussion are presented in Chapter 6. Finally, in the last Chapter, the
major conclusions are summarized and some future work are also summed up.
Chapter 2
Literature Review
This chapter describes the literature review related with the diabetic neuropathy (section 2.1),
focusing on the problems associated with this disease and the main alterations suffered by its
patients (subsection 2.1.1) - gait and plantar pressures alterations.
2.1 Diabetic Peripheral Neuropathy
Diabetes is a metabolic disorder primarily characterized by elevated blood glucose levels and by
microvascular and cardiovascular complications. It is also associated with several neuromuscu-
loskeletal impairments, physical disability and lower health-related quality of life. World Health
Organization (WHO) estimates that 347 million people worldwide have diabetes and more than
80% of live in low-and middle-income countries [5]. In 2012, an estimated 1.5 million deaths
were directly caused by this disease and WHO also projects that diabetes will be the 7th leading
cause death in 2030 [5]. Moreover, in 2012 the economic cost of diabetes in the United States was
estimated to be $245 billion (109), of which $176 billion were direct medical costs, being diabetes
a major cause of cardiovascular morbidity and mortality [6]. Additionally, in Portugal, the Annual
Report of the National Diabetes Centre - "Diabetes: Facts and Numbers" [7] - estimated that in
2013 the prevalence of diabetes in the Portuguese population aged between 20 and 79 years (7.8
million individuals) was 13.0%, i.e, more than 1 million Portuguese in this age have diabetes [7].
Comparing this values with the results from 2009, where the diabetes prevalence was 11.7%, it can
be seen an increase of 1.3 percentage points in the rate of diabetes in Portugal between 2009 and
2013 [7]. Recent advances in knowledge, therapies, and technology have enhanced the ability to
help patients with diabetes. However, the patients still experience several health problems, putting
them at risk for the development of acute and chronic complications [6]. Much of the disability
and cost associated with diabetes are related to the care of chronic complications [6].
Incidence of diabetes and the longer life expectancy of the diabetes patients result in increase
prevalence and clinical importance of musculoskeletal alterations. Connective tissue disorders,
neuropathy, vasculopathy or combinations of these problems may cause these musculoskeletal
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alterations [8], being diabetic neuropathy, among the others, one of the most accused and investi-
gated problems in the pathogenesis of musculoskeletal alterations associated with diabetes [6].
Diabetic neuropathy is a common complication and greatest source of morbidity and mortality
in diabetes patients. The term diabetic neuropathy includes a spectrum of clinical syndromes
with differing anatomic distributions, clinical courses, and underlying pathogenic mechanisms
[6]. Each clinical syndrome is characterized by diffuse or focal damage to peripheral somatic or
autonomic nerve fibers resulting from hyperglycemia. Diabetic neuropathy is typically divided
into diabetic peripheral neuropathy (DPN) and autonomic neuropathy. DPN has been defined
as the presence of symptoms and/or signs of peripheral nerve dysfunction after the exclusion
of other causes (i.e., traumatic, compressive, neoplastic, or other systemic illnesses) [6]. DPN
causes pain or loss of feeling in the toes, feet, legs, hands and arms (figure 2.1) and may cause
muscle weakness and loss of reflexes, especially at the ankle, resulting in compensatory walking
mechanisms, leading to foot deformities, such as hammertoes and the collapse of the midfoot [9].
Additionally, blisters and sores may appear on numb areas of the foot because pressure or injury
goes unnoticed. If an ulceration occurs and is not treated promptly, the infection may spread to
the bone, and the foot may then have to be amputated. Many amputations are preventable if minor
problems are diagnosed and treated in time [9].
Figure 2.1: DPN causes pain or loss of feeling in toes, feet, legs, hands, and arms [9]
In practice, the diagnosis of painful DPN is a clinical one, which relies on the patients de-
scription of pain. The symptoms are distal, symmetrical, often associated with nocturnal exarcer-
bations, and commonly described as prickling, deep aching, sharp, like an electrical shock, and
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burning with hyperalgesia and frequently allodyna upon examination [10]. The symptoms are
usually associated with the clinical signs of peripheral neuropathy, although occasionally in acute
painful DPN, the symptoms may occur in the absence of signs [10].
The prevalence of diabetic neuropathy in newly diagnosed patients with diabetes is estimated
to be 8% and greater than 50% in patients with long-standing disease [6]. However, it is impossi-
ble to accurately approximate the true prevalence of diabetic neuropathy, because the criteria for
diagnosis vary, epidemiologic studies are limited to patients receiving medical care, and diabetes
remains undiagnosed in a large population of diabetes patients. Notwithstanding, several stud-
ies have shown that the prevalence of DPN increases with age and disease duration, and tends to
be more common in patients with type 2 of diabetes mellitus (T2DM) than in those with type 1
(T1DM) [11]. The prevalence of DPN as a function of disease duration is illustrated in figure 2.2.
This figure is from an cross-sectional study of 6487 patients (3˜7 % with T1DM), and shows that
the prevalence of DPN was significantly higher in patients with T2DM (32.1%) than in T1DM
patients (22.7%, P<0.01), and there was a significantly higher correlation between age and preva-
lence of neuropathy in both T1DM and T2DM [11] [2]. Rochester Diabetic Neuropathy Study
[12] also reported that 54% of patients with T1DM with average disease duration of 14.5 years
has DPN, while 45% of T2DM patients with average disease duration of 8.1 years present DPN.
Moreover, Caselli et al. evaluated diabetic patients with different degrees of peripheral neuropathy.
They have shown that the groups with moderate or severe neuropathy had a significantly longer
duration of diasese (P<0.001) [13].
Figure 2.2: Effect of disease duration (left) and age (right) on prevalence of diabetic neuropathy.
Adapted from [2]
Additional studies have shown that smoking, dyslipidemia, and hypertension increase an in-
dividual’s risk of developing diabetic neuropathy. Therefore, the high prevalence of diabetic neu-
ropathy results in significant morbidity, including and increased risk of recurrent lower-extremity
infection, ulcerations, foot and ankle fractures and lower-limb amputations [6]. As a result, the
frightening statistic that diabetic neuropathy is implicated in 50-75% of nontraumatic amputations
is merely an exclamation point in the overall impact [14].
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Improved glycemic control has been shown to improve nerve function in patients with dia-
betes. Intensive glycemic control has also been suggested to reduce the risk of developing diabetic
neuropathy in T1DM patiens. However, the evidence for glycemic control and the prevention of
neuropathy T2DM patients is not as strong [6]. The UK Prospective Diabetes Study (UKPDS)
reported a 25% risk reduction in microvascular complications after 10 years of intensive treat-
ment. However, most of the risk reduction was due by the reduction in retinopathy [15]. Some
studies have shown a slowing of the progression of diabetic neuropathy with improved glycemic
control in patients with type 2 diabetes. Thereby, intensive glycemic control, particularly in early
stages of the disease, seems to provide a long-term benefit for the prevention of diabetic neu-
ropathy [6] [16]. The Epidemiology of Diabetes Intervention and Complications (EDIC) study
followed approximately 95% of the subjects enrolled in the Diabetes Control and Complications
Trial (DCCT) cohort for several years [16]. One of the main goals of this study was to describe the
development and progression of cardiovascular (coronary, peripheral vasculopathy, and cerebral)
T1DM [16]. Additionally, another objective was to examine the long-term effects of differences
in prior diabetes treatment (conventional versus intensive therapy) during the DCCT on the subse-
quent development and progression of diabetes complication and cardiovascular disease in T1DM.
During the EDIC trial, the glycemic separation between the intensively treated group and the stan-
dard treatment group disappeared. Patients with previous intensive treatment of their T1DM had
a decrease in the prevalence of neuropathy that persisted through the EDIC follow-up despite
deterioration of their glycemic control [16].
Several questionnaires have been developed to assist clinicians in the diagnosis of DPN. The
douleur neuropathique 4 questions (DN4) questionnaire can be completed rapidly and is easy
to use, with reported good specificity (83%) and sensitivity (90%) [17]. There are several simple
clinical tests that should be used to screen patients for DPN. The combined use of appropriate tools
and clinical examination has been shown to provide greater than 87% specificity in the detection
of DPN [16]. The most frequently used instrument for detecting neuropathy is the nylon Semmes-
Weinstein monofilament [18]. Inability to perceive the 10g of force a 5.07 monofilament applies
is associated with clinically significant large-fiber neuropathy [18]. In some prospective studies,
the Semmes-Weinstein monofilament identified persons at increased risk of foot ulceration with
a sensitivity of 66% to 91%, a specificity of 34% to 86%, a positive predictive value of 18% to
39%, and a negative predictive value of 94% to 95% [19] [20] [21]. However, the accuracy of the
monofilament depends on the number of tested points of the feet [18].
Social and economic repercussions due to high morbidity, premature deaths, work disability
and high treatment expenses have increased the concern about diabetes – included health prob-
lems in the population. In order to decrease the morbidity of patients with diabetes, international
guidelines and consensus documents emphasize the need for educating the patients and health
care providers against foot ulcers, amputations, and falls. It has been shown that an intensified
prevention strategy including patient education, foot care and footwear is cost-saving [8].
Current understanding of the pathophysiology is complicated and incomplete, but basic ex-
perimental research is on the threshold of producing the first disease-modifying therapies. The
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available treatments consist in an array of drugs and are modestly to moderately effective in re-
lieving symptoms but are limited by adverse effects and drug interactions [14].
One of the biggest problems of DPN is that 50% of patients have no symptoms and are only
diagnosed by careful, regular and thorough clinical examination [3]. Therefore, in early stages
this condition may be unnoticed. Hereupon, it is important to identify parameters that allow dis-
criminating early peripheral neuropathy stages in order to take protective measures to prevent feet
injuries, and improve the diagnosis, treatment, and follow-up of DPN patients.
2.1.1 Alterations associated with DPN
2.1.1.1 Gait Alterations
DPN usually starts with sensory nerve damage and progresses with the motor involvement, muscle
atrophy and physical dysfunction. Significant deficits in vibration sense, tactile sensitivity, propri-
oception and kinesthesia, all leading to postural instability and uncoordinated gait, increases the
risk of foot ulcers and falling [8].
Computerized gait analysis has been used to objectively quantify changes in the biomechanics
of walking. Thus, it can be used to objectively study musculoskeletal mechanisms and strategies,
developed to compensate for some pathological conditions of human body. Identification of the
movement adaptations and possible associated clinical parameters might help prevention and di-
agnosis of future risks of ulcer development and falls of diabetic patients [8]. Therefore, the main
goal of oriented rehabilitation programs for diabetic patients is to prevent postural instability, gait
deviations, falls and/or foot ulcerations through exercises to maintaining muscle strength, balance
and coordination [8].
Gait analysis of DPN patients has received an increasing interest. Patients with diabetes, and
peripheral neuropathy have a high incidence of injuries during walking and a low level of perceived
safety [22]. Various authors have found an association between neuropathy and gait abnormalities
and/or falls. Cavanagh et al. [23], for example, demonstrated that peripheral neuropathy affects
gait and posture. They reported that subjects in a group of patients with DPN were 15 times more
likely to report an injury (fall, fracture, sprained ankle, or cuts and bruises) during walking or
standing than subjects in a control group of patients with diabetes but no peripheral neuropathy
(NDPN) [23]. They stated that peripheral neuropathy, rather than ocular changes are responsi-
ble for gait problems and conclude that neuropathy could well represent the mechanism for gait
abnormalities and increased risk of falls [23]. Moreover, Katoulis et al. [24] have demonstrated
that diabetic subjects with peripheral neuropathy show alterations in some gait parameters during
walking. These alterations could facilitate foot injuries, thus contributing to frequent foot ulcer-
ation [24]. In addition, some studies suggested that DPN is a risk factor for developing plantar
ulcers once most of these ulcers are thought to develop during walking [22].
Although, several studies have suggested that altered gait patterns of diabetic persons are
largely related to peripheral neuropathy [23] [24], similar aberrations have been detected in di-
abetic patients free of clinically significant neuropathies [8]. Yavuzer et al. [8] have shown that
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NDPN patients had significant gait deviations, such as slower gait, shorter steps, limited knee and
ankle mobility than normal control group. However, these gait abnormalities were not found in
DPN patients, suggesting that neuropathy may be not the only reason for gait deviations of diabetic
patients [8]. Furthermore, Yavuzer et al. [8] have presented that walking velocity and step length
of NDPN group were less than DPN patients, and control group, supporting previous findings that
the decrease in walking speed in patients with diabetes may be a compensatory strategy adopted
to improve stability or to maintain balance rather than direct result of neuropathy [8]. Petrofsky
et al. [25] also found gait impairments in NDPN patients. These authors emphasized that whatever
the mechanisms, diabetic patients develop gait alterations well before the appearance of peripheral
neuropathy, suggesting that in diabetic patients free of peripheral neuropathy, it may be a loss of
motor control that causes diabetic ulcers [25].
This apparent contradiction between authors underscores the need for further research in order
to understand the role of DPN in gait abnormalities and the increased risk of falls in diabetic
patients.
In most existing studies authors assessed gait indoor, i.e. in specialized gait laboratories or on
a flat indoor surface. Few authors have attempted to evaluate gait under various conditions such as
irregular surfaces, a poorly lit pathway or an obstacle course since gait analysis performed indoors,
on a predefined, clean and essentially flat, specific pathway is not representative of a real life situ-
ation [26] [27]. For this reason, Allet et al. [26] considered that gait analysis should be performed
in a real life environment to correctly understand what makes individuals fall. Thus, they analyzed
gait parameters in diabetic patients and investigated the surface effect on their walking pattern
compared to healthy controls. Diabetic patients with and those without neuropathy, adjusted to
the variety of different surfaces using identical strategies. These strategies were similar to those
used by healthy controls. In general, the surface altered significantly all gait parameters. This
study identified gait abnormalities in both diabetic patient groups (with and without neuropathy)
and the deterioration of gait parameters increases with disease severity (neuropathy). Patients with
neuropathy have more difficulty adapting their gait to irregular surfaces when compared to those
without neuropathy, or healthy controls [26]. However, they have shown that some of the gait
parameters of the diabetes patients are already significantly altered before neuropathy is clinically
detected [26]. Although Allet et al. [26]
Richardson et al. [27] identified differences in gait based on fall history among a group of older
subjects with peripheral neuropathy in 2 environments: standard and challenging. The analysis of
gait in the challenging environment effectively identified gait characteristics associated with falls
in an older population with DPN, whereas analysis of gait in the standard environment did not
[27]. Therefore, peripheral neuropathy-associated gait dysfunction is more sensitively detected on
an irregular rather than on a flat surface [27]. Additionally, Menz et al. [28] have shown that DPN
participants had reduced walking speed, cadence, and step length, and less rhythmic acceleration
patterns at the head and pelvis compared with controls. These differences were particularly evident
when participants walked on the irregular surface [28]. Participants with DPN also presented
impaired peripheral sensation, reaction time, and balance [28].
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Gaining insight into gait pattern alterations that occur in NDPN individuals is essential for
developing strategies to effectively prevent mobility impairment in early diabetes stages[29]. Ko
et al. [29] compared gait parameters from the fast-walking (walking as fast as possible) and usual
walking (like “walking in the street”) between participants with and without T2DM. This study
have shown that during fast-walking all gait pattern differences, e.g. shorter stride length, indi-
cate that persons with diabetes tend to have a less efficient gait pattern with higher intensity effort
than during usual walking [29]. It is noteworthy that these inefficiencies are present in persons in
relatively early stages of diabetes who have not yet developed the full range of diabetes compli-
cations. It would appear that fast-walking task, which places greater demand on motor control, is
an important adjuvant to better differentiate gait performance in generally healthy older persons
in the early stages of potentially debilitating conditions such as diabetes [29].
Some studies suggested that gait analysis during turns provides a much more sensitive analysis
of the early onset of gait abnormalities [25]. This is due to the inability of the body to compensate
for rapidly changing gravity vectors if any vestibular or sensory pathology is present. As such,
falls do not usually occur during walking in a linear path but rather in turns. Thus, Petrofsky et al.
[25] performed one of the first studies that analyzed the gait of subjects with diabetes making
turns. This study have shown that diabetes patients walked significantly slower and used more
steps to complete the linear walk compared to control. These characteristics were seen when the
subjects do not performed turns, however, during turns, gait was even slower and the steps wider
[25]. In addition, velocity of the turns in subjects with diabetes was about half the velocity when
compared to control subjects. Stride was much wider in the subjects with diabetes than in control
subjects [25].
Some studies have indicated that even with mild or none neuropathy, diabetic patients with
poor glycemic control have similar gait deviations increasing the risk of falling and foot ulcers [8],
suggesting that glycemic control improves motor control in diabetic patients.
2.1.1.2 Plantar Pressures Alterations
The presence of foot ulcers in the clinical history of a diabetic subject is a sign of worsening
neuropathy [30]. This happens because the development of ulceration is considered the probable
result of progressive neurological, vascular, and autonomic damage. These events only prove the
progression of the disease over time [30].
The research literature has reported the existence of a strong association between diabetic
neuropathy and higher plantar loads that may be responsible for foot ulceration and re-ulceration.
One of the first studies on plantar pressure in diabetic patients was published by Stokes et al in
1975 [31]. They noted not only that patients with present ulcer had the highest maximum load,
but when compared with normal subjects, a lateral shift in pressure (an increased pressure in 4th
and 5th metatarsal heads) was observed [31]. Since then, many studies confirmed a high plantar
pressure as a principal factor in the development and non-healing of plantar ulcers in diabetic
patients [32]. However, some authors have not found elevated peak pressures for all ulcerated
patients [33]. Hereupon, the coexistence of increased peak pressure and the pathogenesis of ulcer
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formation are considered speculative at best. Although re-ulceration is common in patients with
diabetic neuropathy even with adequate footwear use, the differences in the distribution patterns of
plantar pressure following a completely healed ulcer and its relationship with ulceration recurrence
after one year of resolution is still unknown [34].
An ideal approach to study the biomechanical effects of diabetic neuropathy in ulcer develop-
ment would be a long-term longitudinal study to analyze plantar pressure distribution during gait
before and after the ulcer formation. A short-term option is a comparison study of two different
groups of neuropathic patients at different stages of the neuropathy to address deficits in sensitiv-
ity and previous history of ulceration in order to predict the incidence of re-ulceration under high
plantar pressures [34]. Based on this, Bacarin et al. [34] investigated and compared the influence
of previous history of foot ulcers on plantar pressure variables during gait. This study has shown
that neuropathic groups, both non-ulcerated and ulcerated, presented alterations in plantar pres-
sure distribution patterns, and the ulcerated patients presented higher loads than non-ulcerated.
The history of foot ulcers in the clinical history of the diabetic neuropathy subjects influenced
plantar pressure distribution, resulting in an increased load under the midfoot and rearfoot and an
increase in the variability of plantar pressure during barefoot gait [34]. In addition, Boulton et al.
[35] have shown that all patients with diabetic neuropathy and an history of ulcers had abnormally
high pressures at the previous site of ulcers, compared with only 31% of feet with no evidence
of ulceration, supporting the theory that the long-term effects of peripheral neuropathy, with loss
of pain sensation and proprioception and weakness of the intrinsic muscle of the foot, have been
said to alter the weight distribution under the foot, leading to increase loading under the metatarsal
heads. In other words, they suggested that foot pressure abnormalities might represent an early
marker of DPN [35]. Shaw et al. showed that vertical forces through the heel during walking were
increased in diabetic neuropathy and they suggested that this might explain increased plantar heel
pressures and contribute to the risk of foot ulceration [36].
Information in the field of plantar pressure distribution in T2DM without any complication
and with short duration of the diabetes was limited [30]. Therefore, Pataky et al. [30] quanti-
fied the abnormalities and distribution of both plantar pressure and its duration in T2DM patients
without complications during normal walking and compared with healthy subjects. Their results
demonstrated plantar pressure abnormalities in diabetic patients without complications, suggest-
ing that abnormalities appear before loss of sensation, as an early sign of diabetic neuropathy
[30]. They have shown that the more the plantar surface is reduced, the more the foot-floor con-
tact is prolonged at each step. This could contribute to ulceration in the neuropathic where the
contact plantar surface may be even more reduced as a result of additional neurological or vas-
cular pathology [30]. In short, they conclude that plantar pressure elevation, together with the
prolonged duration of the foot–floor contact time may be an early sign of neuropathy once these
abnormalities were detected even in diabetic patients without complications [30].
The mechanisms by which the peripheral diabetic neuropathy causes plantar pressure elevation
are well described [30]. One relates to altered proprioception with an imbalance between the long
flexors and extensors of the toes, which, in its advanced form, give rise to the claw toes and
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prominent metatarsal heads. Clawing of the toes is accompanied by anterior displacement of the
submetatarsal head fat pads. These structural changes lead to increased supinatory moments in
neuropathic feet with an increased pressure under 4th and 5th metatarsal heads. Such changes in
plantar pressure may occur before clinically evident peripheral neuropathy [30].
The tendency to plantar pressure displacement has been reported by Caselli et al. [13]. They
evaluated both the relationship between forefoot and rearfoot plantar pressures in diabetic pa-
tients with different degrees of peripheral neuropathy and their role in ulcer development [13].
They observed that both rearfoot and forefoot pressures were increased in diabetic neuropathic
foot, whereas the forefoot-to-rearfoot plantar pressure ratio increased only in severe diabetic neu-
ropathy, indicating an imbalance in pressure distribution with increasing degrees of neuropathy.
However, they did not evaluate non-diabetic controls [13].
In summary, several studies have shown that high plantar foot pressures in diabetic patients
are strongly predictive of subsequent plantar ulceration, especially in the presence of neuropathy.
Moreover, Pataky et al. [30] also suggested that prolonged duration of foot-floor contact duration
may be an early sign of diabetic neuropathy [30] and should also be taken in consideration.

Chapter 3
Methodology
This section presents the technological concepts and devices used to achieve the goals of this study.
3.1 Machine Learning Technology
A major problem in bioinformatics analysis or medical science is to attain the correct diagnosis
of certain important information. For the ultimate diagnosis, generally many tests are done that
involve clustering or classification of large scale data. All of these test procedures are said to be
necessary in order to reach the ultimate diagnosis. However, too many tests could complicate the
main diagnosis process and lead to the difficulty in obtaining the end results, particularly in the
case where many tests are performed [37]. This kind of difficulty could be resolved with the aid
of Machine Learning (ML) which could be used directly to obtain the end result with the aid of
several artificial intelligence techniques.
There are several applications for ML, the most significant of which is data mining. People are
often prone to making mistakes during analyses or, possibly, when trying to establish relationships
between multiple features. This makes it difficult for them to find solutions to certain problems.
ML can often be successfully applied to these problems, improving the efficiency of systems and
the designs of machines [37].
ML covers such a broad range of processes that it is difficult to define it precisely. A dictionary
definition includes phrases such as to gain knowledge or understanding of or skill by studying the
instruction or experience and modification of behavioral tendency by experienced zoologists and
psychologists study learning in animals and humans. The extraction of important information
from a large pile of data and its correlation is often the advantage of using machine learning [37].
Several studies have reported, in literature, the use of ML on diagnosis of diabetes complica-
tions:
• Carnimeo and Giaquinto [38] proposed automatic detection of diabetic symptoms in retinal
images by using machine learning technology
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• Radha and Rajagopalan [39] introduced an application of fuzzy logic to diagnosis of dia-
betes
• Sapna et al. [40] proposed a technique based on diabetic neuropathy. They used the risk
factors and symptoms of diabetic neuropathy to make the fuzzy relation equation.
The ML process used to characterize the gait follows the signal processing flow presented in
figure 3.1. Following, it will be explain, in detail, each step of this process.
Figure 3.1: Schematic representation of a machine learning process
3.2 Data acquisition
To perform learning techniques there is the need to collect a set of data for studying. The sensors
to collect this data were chosen based on the limitations associated with DPN patients (presented
in last chapter). Ideally, in order to identify stages of DPN, the data should be collected from
healthy subjects, NDPN, and DPN patients. Following, the sensors used to collect the gait data
are explain in detail.
3.2.1 Inertial Sensors
As was mentioned in subsection 2.1.1, one of the alterations associated with DPN patients is gait
abnormalities. Thus, one of the focus of this study was sensors that allow the detection of temporal
and spatial features of gait.
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The traditional approach to quantitative motion analysis has proven to be clinically very useful.
However, the implementation can be critical, once traditional motion analysis systems are quite
expensive and difficult to be operated, only capture a limited number of consecutive gait strides,
and these systems must operate in controlled environments, which hinders them from gathering
information about the extent subjects perform functional activities outside the laboratory setting.
These reasons lead to the recent surge of interest in ambulatory monitoring systems [41]. There-
fore, inertial sensors, e.g., accelerometers, used alone or combined with other sensing devices, are
becoming increasingly popular, due to their low cost, small size, light weight, and limited power
requirements [41].
An accelerometer basically uses the fundamentals of Newton’s Laws of Motion, which say
that the acceleration of a body is proportional to the net force acting on the body. Knowing the
proportionality quotient (mass of the object), and all the forces (measured with the sensors), it is
possible to calculate the acceleration. By taking the integral of the acceleration, it is obtain the
velocity, and by integrating the velocity, it is obtain the position [1].
The signal obtained with accelerometers has two components, a gravitational acceleration
component (static) - provides information on the postural orientation of the subject - and a body
acceleration component (dynamic) - provides information on the movement of the subject [42].
In this context, several studies have been published with the purpose of demonstrating that
inertial sensors can be used to detect simple temporal or spatial features of gait:
• Bouten et al. [43] developed a triaxial accelerometer and a portable data processing unit for
assessment of daily physical activities.
• Veltink et al. [44] proposed and tested a three dimensional inertial sensing system, embed-
ded in a two-channel implantable foot-drop stimulator, for measure foot movements during
gait.
• Sabatini et al. [41] concluded that foot inertial sensing is a promising method for which sev-
eral applications in rehabilitation, sport medicine, and health monitoring can be considered
Nowadays, inertial sensors can be find built-in smartphones. These devices are practical, small
and unobtrusive, and have the possibility to be wearable, which allows to work always next to the
user, in real-time, and be used for long-term monitoring. Therefore smartphones can be used to
acquire accelerometer data, being considered by the users an important personal device, with an
exponential availability.
3.2.2 Plantar Pressure Sensors
Plantar pressures abnormalities are also presented in diabetes patients with neuropathy. There are
a variety of plantar pressure measurement systems but in general they can be classified into one
of the two types: platform systems and in-shoe systems [45]. In this work, the attention it will be
focus on in-shoe systems.
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In-shoe plantar pressure systems have been widely used by researcher and clinicians in the
fields of clinical rehabilitation, ergonomics, and sport activities [46]. Such systems allow moni-
toring of foot plantar pressure during either static or dynamic activities, allowing measurements
in real conditions without the limits of laboratorial setup. The operating principal behind each
in-shoe system is generally the same: these systems use different sensors/insoles to collect and
send to a hub, generally attached to the lateral malleolus or pelvic girdle, which records data in a
memory card or transfers them in real-time to a computer by cable, bluetooth, or other wireless
means [46].
WalkinSense (Kinematix SA, formerly Tomorrow Options) (Figure 3.2) is a user-friendly
device designed for in-shoe monitoring and long-term storage of plantar pressure and spatial-
temporal parameters during locomotion, such as gait speed, distance traveled, stride length and
frequency, without the need for a standardized calibration and the constraints of a laboratorial
setup [46]. This device allows for daily, continuous monitoring of plantar pressure through a data
acquisition and a processing unit and individual sensors for plantar pressure measurement which
can be attached to either and insole or patient’s sock [47]. Some characteristics of the WalkinSense
system are presented in table 3.1.
Figure 3.2: WalkinSense Device. Adapted from [48]
Table 3.1: WalkinSense System Characteristics. Adapted from [46]
WalkinSense System
Weight 68g
Length 78mm
Width 48mm
Thickness 18mm
Components
Micro-electromechanical system
Triaxial accelerometer
Gyroscope
Force-sensing Piezoresistors
Sensor Size 1.8cm
Number of Sensors 8 (freely positioned under or over any insole)
Frequency 100 Hz
Operation’s Mode Offline mode: data are stores to an SD memory card;
Real-time mode: data communicated to a PC through bluetooth technology
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One preliminary study has already explored the repeatability of the plantar pressures recorded
by the WalkinSense. The system was found to be as repeatable as other plantar pressure measure-
ment systems. However, when compared to F-Scan, WalkinSense appears to consistently report
higher pressure values. Nevertheless, the authors assessed only three subjects and no statistical
procedure was performed, suggesting that further investigation with a larger sample size should
be performed to fully ascertain the repeatability and reliability of the system [47]. Another pre-
liminary study assessed the spatial-temporal parameters of the WalkinSense in a small sample of
15 participants and found good accuracy and repeatability for these parameters [49]. Therefore,
Castro et al. [46] measured the accuracy and repeatability of the gait analysis performed by the
WalkinSense system. They have shown that the WalkinSense has good-to-excellent levels of accu-
racy and repeatability for plantar pressure variables during static-bench and dynamic gait analysis
[46].
3.3 Preprocessing Techniques
The goal of the preprocessing step is transform the raw data into some desired form from which
useful features can be extracted [50]. The preprocessing techniques further explain were only
applied to accelerometer data.
The accelerometer in Android phones measures the acceleration of the device on the x (lateral),
y (vertical), and z (longitudinal) axes, as it is shown in figure 3.3. The acceleration is measure in
the International System units, m/s2.
Figure 3.3: Coordinate system (relative to a device) that’s used by the Android Sensor API.
Adapted from [51]
In some studies, features from individual acceleration axes may be important in determining
activities where directional information is relevant [52]. However, in this study, the overall theme
in the acceleration was deemed to be sufficient for the recognition of gait patterns. As a result, the
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first step taken in the preprocessing techniques was merge the three-dimensional input signal into
one acceleration magnitude. The magnitude of the acceleration vector was determined by taking
the euclidean magnitude of the three individual acceleration values (equation 3.1) [52]
α =
√
x2+ y2+ z2 (3.1)
Irregular sampling rates created by the Android framework’s implementation of sampling
mechanisms and the noise inherent in discrete physical sampling of continuous functions are the
two principal sources of noise in the received signal [52]. The process used to handle the irreg-
ular sampling of the received acceleration signal was data linearization. This process consists in
choose a desired regular sampling rate and then interpolates all the holes in the data using linear
interpolation [52]. One significant problem in the linearization process was to determine an ideal
sampling rate. In order to ensure that not too much data was calculated via interpolation - which
could have resulted in a false recreation of the original signal, the sample frequency chosen was
100Hz once is the sample rate of the Walkinsense.
After linearization, in order to reduce any additional noise, the signal was then ran through
a 5-point smoothing algorithm. This algorithm calculates each point to be the average of its four
neighbors, the two nearest before and the two nearest after [52]. The 5-point smooth was chosen so
that spikes with an observable, steady progression would be preserved while sudden spikes would
be eliminated [52]. Finally, the signal was passed through a 4th order Butterworth high-pass filter
to remove the gravitational acceleration component (static - provides information on the postural
orientation of the subject) [53]. The cut-off frequency was set at 1Hz [53].
3.4 Feature Extraction
The extraction of features from the collected gait signal is crucial for the efficient gait characteri-
zation. In this study, features could be extracted from accelerometer and plantar pressures data.
From accelerometers, it is possible to extract feature from two broad domains - time and
frequency-domain [54]. However, a combination of them is desirable.
Time-domain features are often used to select key signal characteristics or features. These
metrics consist in simple mathematical and statistical measurements used to extract basic signal
information from raw data [54]. Additionally, frequency-domain features have been often used to
capture the repetitive nature of a sensor signal [54].
The Walkinsense system provides information, that allows the extraction of plantar pressure
and spatial-temporal parameters. As mentioned in subsection 2.1.1, these characteristics are also
crucial to evaluate the gait of DPN patients.
During this work, different experiments were performed. Therefore, the the features extracted
for each performed analysis are summarized further, in detail.
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3.5 Feature selection
After feature extraction, the next step is select the most relevant and informative features. In
machine learning, feature selection is used to find the subset of the available input features that
accurately predicts the output and remove the ones that are redundant and/or irrelevant. Conse-
quently, feature selection improves predictive performance of the model, provides faster and more
cost-effective predictors and provides a better understanding of the underlying process that gen-
erated the data. Two different methods were tested for feature selection: principal components
analysis (PCA) and forward selection (FS).
PCA is a useful statistic technique and is a common method for finding patterns in data of
high dimension [55]. After find these patterns, PCA compress the data by reducing the number of
dimensions, without much loss of information [55].
PCA was applied for the final feature matrix so that the features would undergo an orthogonal
transformation to be converted to a set of different features called principal components. The main
steps of the PCA are following described [55]:
1. Get feature matrix: MxN matrix, where M are the observations and N the number of
features.
2. Subtract the mean: the mean is subtract from each of the features. The mean subtracted is
the average across each feature. This produces a dataset whose mean is zero.
3. Calculate the covariance matrix: covariance is always measured between 2 features. In
this study, the dataset has more than 2 features, thus there is more than one covariance measure-
ment that can be calculated. The number of different covariance values that can be calculated for
n-features data is given by the following equation:
n!
(n−2)!∗2 (3.2)
In addition, a n-features dataset originates a square matrix of order n, where each entry is the result
of the covariance calculated between two separate features.
4. Calculate the eigenvectors and eigenvalues of the covariance matrix: The eigenvectors
extracted from the covariance matrix allow the characterization of the data. let A be an n x n
matrix. The number λ is an eigenvalue of A if there exists a non-zero vector υ such that Aυ = λυ
In this case, vector υ is called an eigenvector of A corresponding to λ . From a square matrix of
order n it is possible to extract n eigenvectors.
5. Choosing the principal components: the eigenvectors extracted from the covariance ma-
trix are order by the correspondent eigenvalues, from highest to lowest. This gives the compo-
nents in order of significance. In fact, the eigenvector with the highest eigenvalues is the principal
component. After having the components in order of significance, it is possible to ignore the com-
ponents of lesser significance. Some information is lost, however if the eigenvalues is small, the
information lost is not significant. In short, the choose of some principal components leads to data
compression and dimensionality reduction.
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FS method selects the most relevant attributes through a highly efficient implementation of the
forward selection scheme. This method starts with an empty selection of attributes and, in each
round, it adds each unused attribute. For each added attribute, the performance is estimated using
inner operator. Only attributes giving the highest increase of performance is added to the selection.
Then a new round is started with the modified selection [56]. The iteration ran as long as there was
any increase in performance. This implementation avoids any additional memory consumption
besides the memory used originally for storing the data and the memory which might be needed
for applying the inner operator [56].
3.6 Classification
The development of robust pattern classifiers from limited training set of observations (i.e, fea-
tures vectors) has long been one of the most relevant and challenging tasks in in machine learning
and statistical pattern recognition [57]. In all machine learning algorithms, the goal of the learning
algorithm is to build a model which makes accurate predictions on the training set. Therefore, ma-
chine learning classifiers tend to perform very well on the data they were trained on (phenomenon
called overfitting) [58]. However, training set accuracy is not a good indication about the classifier
performance when classifying unseen data. Cross-validation is a tool meant for evaluating the per-
formance of a system and its accuracy. In order to avoid the overfitting, cross-validation precess
divides the dataset into a large training set and a smaller validation set, then train on the training
set and use the validation set to measure the accuracy [58]. However, to assure that the data is not
biased it is important to take two considerations [58]:
1. Validation set should be diverse. Thus, the validation set should be randomly select from
the existing collection of data;
2. Accuracy and usefulness of the cross-validation process depends on having a dataset repre-
sentative of the range of possible expected inputs.
Cross-validation method has different approaches to select the training and validation sets. In
this study, the method used was k-fold cross-validation, which consists in divide the data into k
folds (in this case 10 folds) [58]. One fold was designated as the validation set, while the remaining
nine folds were all combined and used for training. The validation accuracy was computed for each
of the ten validation sets, and averaged to get a final cross-validation accuracy [58]. This process
is shown in figure 3.4.
After split the dataset into train set and validation set, classifiers were applied to predict the
unseen data. The intention of using a different classifier for the same conditions was to evaluate
the differences in terms of performance. Based on literature [50] [59], the classifiers chosen were
k-nearest neighbours (kNN) and support vector machine (SVM).
The kNN is a non-parametric classification method, which is simple but effective in many
cases [60]. Classification of a test example is done by finding the training set example that is
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Figure 3.4: 10-fold cross-validation. The accuracy numbers shown are just for illustration.
Adapted from [58]
most similar to it based on the lowest euclidean distance, considering the entire feature vector,
and assigning the label of this nearest neighbour to the test sample [61]. This algorithm contains
following three steps to classify objects [62]:
1. Calculate distances of all training vectors to test vector;
2. Pick k closest vector;
3. Calculate average/majority.
If k=1, then the object is simply assigned to the class of the its nearest neighbour [62]. The
best choice of k depends upon the data; generally, larger values of k reduce the effect of noise on
the classification, but make boundaries between classes less distinct. Choosing an appropriate k is
essential to make the classification more successful [62].
Nearest-neighbour classification works very well if there is a small number of features, it tends
to fare worse in situation where there are many features and only a few are informative. Hence, it
is generally used in conjunction with feature selection methods [61].
SVM is a machine learning tool and has emerged as a powerful technique for learning from
data. The aim is to find an optimal separating hyperplane (OSH) between two datasets. SVM finds
the OSH by maximizing the margin between the classes [63]. In the case of linearly separable data,
once the OSH is found, data points that lie on its margin are known as support vector points, and
the solution is represented as a linear combination of only these points. Other data points are
ignored. Figure 3.5 represents an example of SVM method.
There are different ways to evaluate the performance of a recognition algorithm. In this study
the metric used was accuracy (equation 3.3 [64]) which estimates the overall success rate, it is
measure of the global performance of the algorithm in what concerns correct decisions [64].
accuracy =
T P+T N
T P+T N+FP+FN
(3.3)
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where TP, TN, FP, and FN are true positive, true negative, false positive, and false negative,
respectively. These values are obtained from the confusion matrix.
Figure 3.5: An example of two-class (+ and ◦) problem showing optimal separating hyperplane
(dotted line) that SVM uses to divide two groups data and the associated suppor vectors. Adapted
from [63]
Chapter 4
Preliminary Tests
This chapter describes and evaluates the preliminary tests. The purpose of these tests was to infer
the more suitable experimental protocol to identify stages of DPN. Two main goals were identified:
1. Evaluate if the velocity should be controlled during the data acquisition.
2. Evaluate if the data acquisition should be performed on a challenging environment, since
diabetes patients have a tendency to have a less efficient gait pattern in this condition.
These preliminary tests were performed on a dataset collected at Fraunhofer AICOS installa-
tions, with healthy volunteers. After data collection, ML methodology was implemented.
4.1 Methodology
The input of the system was accelerometer data collected from healthy subjects walking with
different speeds and in different environments. In order to reach the goals of these preliminary
tests two classifications were performed: discriminate walking speeds and distinguish gait envi-
ronments.
The methodology implemented was already explain, in detail, in section 3.1. PCA and FS were
applied to select suitable features. SVM and kNN performed the classification. The processes used
to record the dataset and extract the features are explained further in detail.
4.1.1 Data Acquisition
Five healthy subjects participated in the acquisition of this dataset. The accelerometer data was
acquired from smartphones (Samsung GalaxyS and Nexus 5) placed on the front pockets of the
trousers. Each participant walked across a 63 m corridor with three different walking speeds:
slow, normal, and fast. Additionally, in the second part of the experiment, each subject walked
on a treadmill with three controlled walking speeds: 0.56 m/s, 1 m/s, and 1.39 m/s. Table 4.1
summarizes the experiments performed by each subject.
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Table 4.1: Experimental Protocol
Experimental Protocol
Walking Environment Walk on 63m corridor Walk on treadmill
Walking speed Slow Normal Fast 0.56 m/s 1 m/s 1.39 m/s
4.1.2 Feature Extraction
During the experiment, only accelerometer data was collected. Initially, the accelerometer data
was divided into sequential windows in order to extract features from each window. One of the
most used approach to split the data is the sliding window technique, where the signal is divided
into equal windows with no gaps. A sample window of 512 samples with an overlap of 50%
were chosen based on the recommendations of prior studies, because it was deemed sufficient to
characterize the gait [52].
As mentioned in section 3.4, it is desirable extract a combination of time and frequency-
domain features from the accelerometer data.
Tables 4.2 and 4.3 summarize and explain the extracted time and frequency-domain features.
Following, the wavelet coefficients extraction is describe in detail.
Fourier Transform technique is a commonly used signal transformation which allows the rep-
resentation in the frequency domain (or spectrum) important characteristics of a time-based signal
[54]. However, one of the major shortcomings of the Fourier transform is that it does not offer
good localization in time,i.e. the transformed representation contains only information in the fre-
quency domain [50]. The wavelet transform is a technique that cuts up the data into different
frequency components, and then studies each component with a resolution matched t its scale
(time-frequency representation) [50]. The wavelet transform of a signal depends on two variables:
scale (or frequency) and time, and provides a tool for time-frequency localization [50].
A mother wavelet ψ (x) is a finite length and fast-decaying oscillating waveform. The mother
wavelet is origins an entire family of wavelets by means of two operation: dyadic dilations (repre-
sented by j)and integer translations (represented by k) [50]:
ψj,k(x) = 2
j
2ψ(2 jx− k) (4.1)
The set {ψ j,k, j,k∈ Z} constitutes a complete orthonormal system for L2(R) [50].
A wavelet transform is the representation of the original signal by wavelets [50]:
cj,k = 〈 f (x),ψj,k(x)〉 (4.2)
f (x) =
∞
∑
j
∞
∑
k
cj,kψj,k(x) (4.3)
where the 〈.〉 is the inner product operator and c j,k are called wavelet coefficients.
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Multiresolution analysis (MRA) is one wavelet method which decomposes the signal into
approximate spaces and detail spaces. One of the advantages of this method is that preserves
interesting features of the original function, but express the function in terms of a relatively small
set of coefficients [50].
It was used the Daubechies 4 tap wavelet family and a multiresolution decomposition level of
4. Figure 4.1 represents a typical decomposition, wheres s is the original signal, d1, d2, ... are
detail coefficients, and a1, a1, ... are approximate coefficients. The original signal is completely
characterized by the coefficients [a4,d4,d3,d2,d1] [50].
After extract the coefficients, in order to include only the most relevant information and reduce
the dimension of the feature space, the Euclidean norms of each level of coefficients calculated:
[‖a4‖,‖d4‖,‖d3‖,‖d2‖,‖d1‖]
Figure 4.1: Multiresolution wavelet decompostion of level 4. Adapted from [50]
Tables 4.2 and 4.3 summarize and explain the time and frequency domain features extracted
from accelerometer data.
4.2 Results and Discussion
This section summarizes the relevant results obtained with the proposed methods as well as a rel-
evant discussion. This section is divided into: preprocessing results, discriminate walking speeds,
and discriminate walking environments.
4.2.1 Preprocessing Results
Figure 4.2 represents the results obtained from the implementation of the preprocessing methods
described in section 3.3
The first graphic, in figure 4.2, represents the raw data after calculate the magnitude of accel-
eration. Then, the signal before and after data linearization can be seen in the first two graphics
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of figure 4.2, respectively. Notice that the signals were very similar. This was expected since data
linearization simply meant to fill in the holes of a sampled signal and should not significantly alter
the signal itself, being the key features of the data preserved [52].
The third and fourth graphics of figure 4.2 show the signal before and after apply the 5-smooth
algorithm, respectively. Notice that before smoothing the signal was jagged and discrete, which
is a key indication of a noisy signal [52]. On the other hand, after smoothing the signal was more
smooth and continuous.
Finally, the last graphic of figure 4.2 illustrates the data after apply the Butterworth filter de-
scribed in subsection 3.3. As expected, the filter removed the gravitational component associated
to the accelerometer data.
4.2
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Table 4.2: Time-domain features [54, 65]
Features Formula Application
Mean Central value of a discrete set of numbers
Data smoothing, axes calibration
Median Separate the higher half of data samples from the lower half
Variance Average of the squared differences from the mean Variability of the data and set a probability distribution
Std Deviation Square root of the variance Indication of the stability of the signal
Min,Max,Range Range is the difference between maximum and minimum sample values Discriminate between walking and running
3rd order cumulant Represents skewness Measure the asymmetry of the data around the sample mean
4th order cumulant Represents Kurtosis Related to the flattening of the distribution, measuring how outlier-prone a distribution is
Table 4.3: Frequency-domain features [50, 54]
Feature Formula Application
Energy Sum of the squares divided by the number of values Identify the mode of transport
Information Entropy Normalized information entropy of the discrete fast Fourier transform coefficient magnitudes excluding DC components Differentiate between signals that have similar energy values
Fundamental, dominant, and median frequency
Lowest frequency of a periodic waveform
Maximum frequency of a periodic waveform
Median frequency of a periodic waveform
Explain the content of the signal spectrum
Determine if a user is walking or running
Wavelet coefficients
Cuts up data, functions, or operators
into different frequency components, and then studies each component with a
resolution matched to its scale
Examine the time-frequency characteristics of a signal
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Figure 4.2: Preprocessing results. First Graphic - raw data; Second graphic - After Linearization; Third graphic - After the application of smooth
algorithm; Fourth graphic - After ran the signal through the high pass filter.
4.2 Results and Discussion 29
4.2.2 Discriminate Walking Speeds
One of the goals of the preliminary tests was evaluate if the velocity should be a controlled pa-
rameter during the data acquisition. As a result, the participants walked with non-controlled and
controlled (through a treadmill) velocities.
The main objective was evaluate the accuracy of the proposed methodology in differentiate
walking speeds. The results using PCA and FS methods to select features were very similar. Thus,
only the results using PCA are presented.
Figure 4.3 shows the average of the velocities and standard deviations in the three walking
speeds for the two environments (corridor and treadmill). As expected, since the velocity was
controlled (0.56 m/s, 1m/s, and 1.39m/s) on the treadmill, the variability of the walking speeds
was lower in this environment comparing with the walk on the corridor. However, figure 4.3
illustrates that, although on the corridor the velocity was not totally controlled (slow, normal, and
fast), it was possible to differentiate three velocity clusters.
Figure 4.3: Average of the velocities and standard deviations in the three walking speeds for the
two tested environments (corridor and treadmill)
The best classification results discriminating walking speeds in different environments (cor-
ridor, and treadmill) are presented in table 4.4. For both classifiers, the best performance was
obtained using the first 14 principal components. The best performance was achieved when the
subjects walked on a treadmill, and the two classifiers (SVM and kNN) presented similar perfor-
mances.
Table 4.4: Best classification results discriminating walking speeds
Accuracy (%)
SVM kNN
Walk on Corridor 86.8 93.3
Walk on Treadmill 89.7 94.7
In addition, figure 4.4 summarizes the performance of the classifiers - SVM (blue line) and
kNN (red line) - discriminating the three walking speeds for the two environments versus the
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number of principal components used for classification. Again, it can be seen that, the accuracy
of the two classifiers was very similar and the classification performance is very stable regardless
of the number of principal components used.
(a)
(b)
Figure 4.4: Accuracy of the classifiers - SVM (blue line) and kNN (red line) - discriminating
walking speeds on corridor (a) and on treadmill (b) versus the number of principal components
used for classification
Compared to other related speed walking recognition methods, the proposed method performs
well since the performance of compared methods are between 68% and 85% [50] [59]. The
implemented ML methodology was capable to differentiate with good accuracy different walking
speeds, suggesting that the velocity should be a controlled parameter during data acquisition.
However, the obtained results were similar comparing walked on corridor and treadmill, and figure
4.3 shows that when the participants walked on corridor were efficient in control the velocities.
Consequently, these results suggest that ask the subjects to walk on a corridor with their normal
walking speed is deem sufficient to control the velocity.
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4.2.3 Discriminate Walking Environments
As referred, the second goal of these preliminary tests was evaluate if the data acquisition should be
performed on a challenging environment. Thus, the objective was discriminate different walking
environments - walking on a corridor and walking on a treadmill.
Analysing figure 4.3, it can be seen that the walking velocities were overlapped when the sub-
jects walked with normal speed on the corridor and walked on the treadmill with 1 m/s. Therefore,
in order to minimize the velocity effect in the classification, these conditions were chosen to dis-
criminate walking environments. In this case, the results using PCA and FS methods to select the
relevant features were significantly different.
Figure 4.5 illustrates the accuracy of the classifiers identifying different walking environments
(corridor and treadmill) versus the number of principal components used for classification. Again,
the behaviour of the two classifiers was similar: the performance increased until the first 5 prin-
cipal components, and then became stable. However, it can be notice that SVM (blue line) had
a better performance, being the best accuracy 75.9% (using the first 10 principal components).
On the other hand, the best accuracy achieved by the kNN was 59.3% using the first 6 principal
components.
Figure 4.5: Accuracy of the classifiers - SVM (blue line) and kNN (red line) - discriminating
walking environments versus the number of principal components used for classification.
Figure 4.6 shows the classifiers performance versus the number of features selected by the
FS process. The accuracy of the SVM was more accurate and very stable, reaching the best
performance (77.7%) using 8 features. On the other hand, the kNN performance was lower and the
accuracy decreased when the number of features used for classification increased. kNN achieved
the best performance (72.2%) using only one feature.
PCA presented worst results than FS method. This may happened for a number of reasons and
it is not linear that PCA should maintain the integrity of the information contained on the original.
As mentioned in subsection 2.1.1, DPN and NDPN patients adjusted to the variety of different
environments using identical strategies, being these strategies similar to those used by healthy con-
trols. The results have shown a low accuracy differentiate walking environments, indicating that
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the subjects should walk on the corridor during the data acquisition since is more representative of
a real life situation.
Figure 4.6: Accuracy of the classifiers - SVM (blue line) and kNN (red line) - discriminating walk-
ing environments versus the number of features selected by FS algorithm used for classification.
4.3 Summary and Conclusions
The main goal of this chapter was to infer the more suitable experimental protocol.
The obtained results suggested that the subjects should be asked to walk on corridor with
their normal walking speed. However, it is important to mention that the preliminary tests were
performed on small dataset (5 healthy subjects). Therefore, for additional validation, a larger
number of subjects should be tested.
Additionally, the obtained results also have indicated that the implemented methodology al-
lowed the characterization of gait from accelerometer data. Hereupon, it is expected that the same
methods could be apply to study the gait of diabetes patients and identify stages of DPN.
Chapter 5
Implementation
This chapter describes the methods used to meet the objectives proposed for this work. After data
acquisition, the data was processed and machine learning methodology was applied in order to
identify gait patterns. Additionally, it was studied suitable features and classifiers with the highest
performance.
5.1 Methodology
The ML methodology implemented was the same described in Chapter 3. Only FS method was
applied to select the more suitable features since, in the preliminary tests, the performance of this
method was higher than PCA. After feature extraction, the further steps were applied using the
RapidMiner Studio. RapidMiner Studio combines technology and applicability to serve a user-
friendly integration of data mining techniques.
SVM and kNN were applied. Since, in kNN classifier, the choice of an appropriate k-value
is crucial to reach an successful classification, the Optimize Parameter operator from RapidMiner
was implemented to find the best value of k. The Optimize Parameters operator find the optimal
values for a set of parameters using an evolutionary approach [66]. This operator has a subprocess,
which executes for a multiple number of times to find optimal values for the specified parameter,
in this case, k-value [66]. The k-values tested by this process ranged between 1 and 100, with
increments of 2 values.
Two datasets were analysed. The acquisition and the extraction of features performed in both
datasets are explain further in detail.
5.1.1 Data Acquisition
Two datasets were analysed. This section explains, in detail, the collection of the both datasets.
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5.1.1.1 Dataset 1
The first dataset was collected by Oliveira and Correia in the study "Evaluation Gait Cycle and
Plantar pressure in Diabetic Patients with Walkinsense", presented in the 20th FIP World Congress
of Podiatry [4]. The aim of this study was evaluate the relationship of changes in the perception
of pressure with cadence, the stride duration, speed, and plantar pressure in type 2 diabetics. To
reach this aim, they followed three steps [4]:
• Selected and characterized 16 healthy subjects and 25 diabetes patients. The exclusion
criteria are summarize in table 5.1.
• Evaluated the presence of peripheral neuropathy in diabetes patients, using the Nylon monofil-
ament 10gr from Bailey (figure 5.1). From the 25 diabetes patients, 9 of them were diag-
nosed with DPN.
• Monitored the gait activity and the plantar pressure trends.
Table 5.1: Exclusion Criteria. Adapted from [4]
Exclusion Criteria
Diabetes Mellitus type 1
Ulcers in the pulp of the 1st finger, and on the 1st and 5th metatarsal head
Keratoses on the pulp of the 1st finger, and on the 1st and 5th metatarsal head
Areas of the necrotic tissue on the pulp of the 1st finger, and on the 1st and 5th metatarsal head
Scars on the pulp of the 1st finger, and on the 1st and 5th metatarsal head
Use some kind of lower limb orthoses and prostheses
Present some painful complaint of lower limb
The subjects performed two tests [4]:
• Conditioned test - walk 10m distance with normal walking speed. This test were examined
by a physician/doctor.
• Free test - walk during two minutes with normal walking speed, without the examination of
any physician/doctor.
In order to monitor the gait activity and the plantar pressures, during each test, the subjects
used the Walkinsense system. The Walkinsense device was placed on the anterior side of the leg
(figure 5.2a) and the eight walkinsense sensors were placed as follows (figure 5.2b) [4]:
• Sensor 1 on the first metatarsal head
• Sensor 2 on the pulp of the 1st finger
• Sensor 3 on the second metatarsal head
• Sensor 4 between the third and the fourth metatarsal head
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(a)
(b)
Figure 5.1: Evaluation of the presence of peripheral neuropathy through the Nylon monofilament
10gr from Bailey. Adapted from [4]
• Sensor 5 on the fifth metatarsal head
• Sensor 6 on the base of the fifth metatarsal
• Sensor 7 on the lateral side of the heel
• Sensor 8 on the medial side of the heel on line with the past sensor 7 in the frontal plane
5.1.1.2 Dataset 2
The second dataset was collected at Fraunhofer AICOS installations, with elderly volunteers. The
tests were performed on 5 healthy subjects and 7 diabetic patients, being the presence of the
diabetic neuropathy evaluated using the 10gr Nylon monofilament. However, the results from the
monofilament test have shown that none of the diabetes patients presented DPN.
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(a)
(b)
Figure 5.2: Placement of the Walkinsense device on the anterior side of the leg [46] (a) and
placement of the eight Walkinsense sensors beneath the flat insole (b). Adapted from [4]
Several studies have estimated that the prevalence of DPN increases with the duration of the
diabetes (as referred in section 2.1). Hereupon, the diabetes patients were divided based on dis-
ease duration - lower and higher than 20 years. This division was made expecting that the obtained
results are similar to the ones encountered if the identification of neuropathy stages was tested. As
a result, 4 and 3 diabetes patients had a disease duration lower and higher than 20 years, respec-
tively. Following, and based on the results from the preliminary tests, the subjects were asked to
walk across a 20m corridor with normal walking speed. During the test, the data was collected
from accelerometers built-in smartphones and plantar pressure sensors (through the Walkinsense
system). The smartphones were placed on the front pockets of the trousers and the accelerometer
data was collected through an application already developed in Fraunhofer. The smatphones used
were the MotoG from Motorola. The sampling rate was not fixed because the phone accelerometer
only registers a value when it changes.
The placement of the Walkinsense device and the eight plantar sensors was the same explained
in subsection 5.1.1.1 (figure 5.2).
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5.1.2 Feature Extraction
Features were extracted to characterize the gait. This section summarizes the features extracted
from each dataset and the methodology implemented to extract them. After feature extraction,
in order to study the highly main differences between the tested groups, the independent sample
T-test with a significance level of 5% (p<0.05) was applied.
5.1.2.1 Dataset 1
In the acquisition of the dataset 1, only the Walkinsense device was used to acquire the data.
Therefore, this dataset does not allow the extraction of features from the accelerometer signal to
identify gait patterns.
As mention in section 5.1.1.1, dataset 1 was collected to another study, thus the features were
already extracted by Oliveira and Correia. Table 5.2 summarizes the extracted features. For each
test, the features were extracted from each step, and then the mean value of all the steps were
calculated and used for classification. Only the tests where it was possible extract all the features
were used for further analysis.
Table 5.2: Features extracted the from database1. Adapted from [4]
Features extracted from the Walkinsense System
Velocity (m/s)
Stride Length (m)
Duration of the gait cycle (s)
Initial time of activation of each sensor (ms)
Final time of activation of each sensor (ms)
Mean pressure of each sensor (Kg/cm2)
Maximum of maximal pressure (Kg/cm2)
5.1.2.2 Dataset 2
In dataset 2, plantar pressure sensors and accelerometers acquired the data. Therefore, it was
necessary split the data from the both sensors in the same partitions. Hereupon, the data was
divided into steps.
Gait cycle is defined as the time interval between two successive occurrences of one of the
repetitive events when walking [67]. In other words, two consecutive steps form a gait cycle.
The gait cycle starts with initial contact of the right sole, and then it will continue until the right
sole contacts the ground again. The left goes exactly the same series events as the right, but
displaced in time by half cycle [67], as it is shown in figure 5.3. Based on this, each step in the
Walkinsense data begun with the activation of the first sensor and ended when the the last sensor
ceased the activation - phase "a" and "d" for the right foot and phase "d" and "g" for the left foot ,
respectively.
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Figure 5.3: Illustration of a gait cycle. Adapted from [67]
Afterwards, the initial and final time of each step, detected in the Walkinsense data, were
used to split the accelerometer data into the same partitions. However, first it was imperative
synchronize the two devices. Therefore, it was necessary determine the initial of the first step in
the accelerometer data.
When the soles touche the ground, representative of the initial of each step, the association
between ground reaction force and inertial force together leads to strongly changes in the accel-
eration signal, forming peaks with high magnitude [67]. These peaks are called true peaks (TP)
[67]. Consequently, the algorithm designed to detect the initial of the first step in accelerometer
data was based on finding these TP [67].
The original signal is denoted as S(n). Initially, it was extracted a set of peaks, P, from S(n). It
was considered a peak if the value of a data point its greater than its previous and next one [67]:
Pdi = {di > di+1∧di > di−1} with i ∈ [1...n] (5.1)
where di is the ith value in S(n). Afterwards, threshold T was estimated to filter TPs. In other
words, the peaks which have magnitudes greater than T was identified as set of TPs, R [67]:
T = µ+σ (5.2)
R = {di ∈ P|di ≥ T} (5.3)
After the definition of the TPs, the initial of the first step in the accelerometer data was defined
as the first TP. Consequently, through the initial of the first step in the accelerometer data, and
initial and final time of each step extracted from the Walkinsense data, it was possible split the
accelerometer data also into steps.
Features were extracted from each step. Since the features extracted from the accelerometer
data in the preliminary tests allowed the characterization of the gait, the same set of features were
extracted from the dataset 2 (tables 4.2 and 4.3). Additionally, table 5.3 summarizes the features
extracted from the Walkinsense.
After feature extraction, all the features were normalized and bounded within [-1,1].
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Table 5.3: Walkinsense features extracted from dataset 2
Walkinsense features extracted from dataset 2
Velocity (m/s)
Stride Length (m)
Duration of the gait cycle (s)
Initial time of activation of each sensor (ms)
Final time of activation of each sensor (ms)
Activation time of each sensor (ms)
Mean pressure of each sensor (Kg/cm2)
Maximum of maximal pressure (Kg/cm2)
5.2 Summary
Two datasets were studied:
• Dataset 1 - collected by Oliveira and Correia in the study "Evaluation Gait Cycle and Plantar
pressure in Diabetic Patients with Walkinsense", presented in the 20th FIP World Congress
of Podiatry.
• Dataset 2 - collected at Fraunhofer AICOS installations with elderly volunteers.
In order to validate the hypotheses of this study it is important collect data, through accelerom-
eters and plantar pressure sensors, on healthy subjects, NDPN, and DPN patients. However, in
dataset 1, the data was collected only with plantar pressure sensors and, in dataset 2, there were
no DPN patients. Therefore, none of the studied datasets met all the desired requirements.
Despite this, two classifications were performed in each dataset. In dataset 1 the goals were
differentiate healthy subjects from diabetes patients and NDPN from DPN patients. Additionally,
in dataset 2, the two performed classifications were distinguish healthy subjects from diabetes
patients and diabetes durations - lower and higher than 20 years.
Machine learning methodology were implemented to perform the classification. After feature
extraction, the next steps taken were feature selection (FS method) and classification (through two
classifiers - SVM and kNN). These steps were implemented in RapidMiner Studio.

Chapter 6
Results and Discussion
This chapter describes the results obtained with the proposed methods and a relevant discussion.
It is divided regarding the results obtained for each analysed dataset.
6.1 Dataset 1
As mention in subsection 5.1.1.1, in the acquisition of dataset 1, the subjects performed two tests
- conditioned and free. Tables 6.1 and 6.2 summarize the clinical details of the subjects and
the performance (accuracy) of the implemented methodology for the conditioned and free test,
respectively. As mention in subsection 5.1.2.1, in dataset 1, only the tests where it was possible to
extract all the features were used for analysis. Consequently, the dataset dimension comparing the
conditioned and free test was different (as it can be noticed in tables 6.1 and 6.2).
For both tests, clinical details of the subjects illustrate that diabetes patients were significantly
older and with a greater BMI than the healthy subjects. Moreover, when comparing no neuropathy
group with neuropathy group, only the disease duration was significantly higher in DPN patients.
Table 6.1: Clinical details of the subjects and machine learning results for the database 1 when
performing the conditioned test
Conditioned Test
No Diabetes Diabetes No Neuropathy Neuropathy
n 13 25 16 9
Age 45.9±13.9 67.8±8.4∗ 66.1±7.5 70.9±9.3
BMI (Kgm2) 26.7±5.47 30.01±3.84∗ 30.1±3.7 29.9±4.3
Diabetes Duration NA 14.2+±10.2 23.4±8.3†
SVM+FS (%) 87.50±16.77 83.33±26.87
kNN+FS (%) (k-value) 89.17±13.46 (1) 86.67±16.33 (3)
Data are means ± SD. NA - Non Applicable.∗ P<0.05vs No Diabetes group. † P<0.05vs No Neuropathy group
The number subjects tested in each group was different, which leads to an unbalance dataset.
When the class sizes differ considerably, most standard classifiers favor the larger class [68]. In
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Table 6.2: Clinical details of the subjects and machine learning results for the database 1 when
performing the free test
Free Test
No Diabetes Diabetes No Neuropathy Neuropathy
n 16 25 16 9
Age 46.2±15.1 65.9±9.9∗ 64.06±9.7 70.0±9.2
BMI (Kgm2) 25.8±5.3 29.9±4.5∗ 29.7±4.1 20.5±4.8
Diabetes Duration NA 13.3+±10.1 21.7+±8.7†
SVM+FS (%) 73.50±19.88 83.33±21.08
kNN+FS (%) (k-value) 80.50±14.71 (9) 90±21.34 (1)
Data are means ± SD. NA - Non Applicable. ∗ P<0.05vs No Diabetes group. † P<0.05vs No Neuropathy group
fact, such as kNN and SVM are based on the assumptions that the training sample set is basic
balance. Therefore, this characteristic of the dataset could affect the classifiers performance.
As mentioned, in dataset 1, for each test, two classifications were evaluated: differentiate
healthy subjects from diabetes patients and distinguish NDPN from DPN patients.
The intention of using a different classifier for the same conditions was to evaluate the dif-
ferences in terms of performance. In general, the kNN performance was higher than the SVM,
being this difference marked in the free test. However, some studies have shown that the kNN
performance decreases when the size of the dataset increases [69] [70]. Therefore, despite these
results, since SVM is a more complex classifier and less influenced by dimensionality problems,
it is expected that SVM performs better than kNN with the increased size of the dataset.
The discrimination between healthy subjects and diabetes patients was more accurate in con-
ditioned test. However, it is important to mention that the fact that the ages of these two groups
were significantly different could have influenced the accuracy of classification. On the other
hand, when differentiating the presence/absence of neuropathy, the highest classifications were
obtained in free test. In free test, the subjects walked during 2 minutes without the examination of
any physician/doctor, being this test more representative of a real life situation, which may have
increased the classifiers performance.
Tables 6.3 and 6.4 compile the features selected by the FS algorithm to distinguish healthy
subjects and diabetes patients in conditioned and free test, respectively. Additionally, tables 6.5
and 6.6 also summarize the features selected in conditioned and free test, respectively, but, in this
case, to differentiate NDPN from DPN patients. The values on these tables refer to the mean and
standard deviation obtained for each group and the p-value obtained from statistical analysis.
In all the performed classifications a relatively lower number of features were selected, spe-
cially in free test, which reduce the computational costs of the process.
As hypothesized, in all the tested conditions, features related to plantar pressures and the
activation time of sensors were selected to perform the classification, suggesting that plantar load
as well as the duration of the foot-floor contact are important to characterize the gait of diabetes
and DPN patients.
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Tables 6.3 and 6.4 show that when the purpose was differentiate between healthy subjects and
diabetes patients the selected features were all related to the forefoot area, suggesting an imbalance
in pressure distribution and duration on diabetes patients since a homogeneous pressure distribu-
tion between the forefoot and the rearfoot has been reported in healthy subjects [71]. Caselli et al.
[13] also reported a imbalance associated with diabetes patients.
The features selected with significantly differences between healthy subjects and diabetes pa-
tients were the final activation time of sensor 6 and the mean pressure of sensor 2 (Tables 6.3
and 6.4 and figure 6.1). The final activation time of sensor 6 was significantly higher in diabetes
patients comparing to healthy subjects, suggesting that diabetes patients have an increase plantar
pressure duration on the base of the fifth metatarsal. Additionally, the mean pressure of sensor
2 was significantly lower in diabetes patients than in healthy subjects. One explanation can be a
reduced toe-contact at the end of footstep. Boulton et al. [72] also reported reduced toe-loading
in diabetes patients without clinically diagnose neuropathy. This abnormal toe-loading can be
explain as an imbalance between the long flexors and extensors of the toes [72].
Tables 6.5 and 6.6 present that the intensity and duration of the plantar pressures were, again,
selected to differentiate NDPN from DPN patients. In this classification, despite other features
have been selected, only the initial activation time of sensor 1 was significantly higher in DPN
patients comparing with NDPN (Tabel 6.6 and figure 6.2). One explanation is that the duration
of foot-floor contact was higher in the sensors that were activated before the sensor 1. On the
other hand, these values also can suggest that DPN patients can have a greater predisposition to
developing pronated feet. The analysis performed by García-Álvarez et al. [73] also have shown a
statistical association between pronated foot and DPN patients group.
Statistical analysis have shown that some features, that were not selected by the FS algorithm,
also presented significantly differences comparing some groups. In appendix, table A.1 detailed
these features. The final activation time of sensor 2 was significantly higher in healthy subjects
than in diabetes patients (table A.1), which supported the hypothesis that the period of toe-contact
at the end of footstep was reduced in diabetes patients comparing with healthy subjects. Further-
more, the mean pressure of sensor 2 was significantly higher in DPN patients than in NDPN, which
could explain the foot-ulceration and re-ulceration associated with DPN patients. As mentioned
in subsection 2.1.1.2, the reported literature has reported the existence of a strong association
between diabetic neuropathy and higher plantar loads.
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Table 6.3: Selected features to distinguished healthy subjects and diabetes patients in conditioned
test
Conditioned Test
No Diabetes Diabetes p∗
Gait cycle Duration (s) 0.98 (0.15) 1.08(0.15) 0.059
Initial time of activation of sensor 1 (ms) 173.3 (73.34) 158.32 (91.81) 0.613
Initial time of activation of sensor 3 (ms) 121.6 (56.37) 139.61 (82.75) 0.487
Initial time of activation of sensor 4 (ms) 71.5 (63.95) 125.88 (85.99) 0.053
Final time of activation of sensor 6 (ms) 472.0 (96.73) 549.99 (86.33) 0.024
Mean pressure of sensor 1 (Kg/cm2) 0.57 (0.23) 0.71 (0.25) 0.168
Mean pressure of sensor 2 (Kg/cm2) 0.34 (0.24) 0.18 (0.14) 0.048
Mean pressure of sensor 3 (Kg/cm2) 0.71 (0.39) 0.80 (0.25) 0.429
Data are means (SD). ∗ P<0.05 is considered significantly different
Table 6.4: Selected features to distinguished healthy subjects and diabetes patients in free test
Free Test
No diabetes Diabetes p∗
Initial time of activation of sensor 5 (ms) 164.44 (97.33) 217.34 (113.37) 0.132
Mean Pressure of sensor 2 (Kg/cm2) 0.31 (0.15) 0.21 (0.14) 0.04
Maximum of maximal pressures (Kg/cm2) 2.57 (0.5) 2.48 (0.7) 0.687
Data are means (SD). ∗ P<0.05 is considered significantly different
(a) (b)
Figure 6.1: Placement of the sensors with significantly different activation time (a) and plantar
pressures (b) in healthy subjects and diabetes patients from dataset 1
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Table 6.5: Selected features to distinguished patients with and without neuropathy in conditioned
test
Conditioned Test
No Neuropathy Neuropathy p∗
Initial time of activation of sensor 4 (ms) 127.38 (79.72) 123.21 (101.26) 0.910
Final time of activation time of sensor 1 (ms) 593.99 (95.01) 622.21(80.03) 0.460
Final time of activation of sensor 2 (ms) 579.26 (68.73) 636.22 (78.66) 0.071
Final time of activation of sensor 4 (ms) 577.42 (90.33) 605.83 (78.66) 0.438
Mean pressure of sensor 1 (Kg/cm2) 0.71 (0.25) 0.70 (0.28) 0.914
Mean pressure of sensor 2 (Kg/cm2) 0.19 (0.16) 0.18 (0.09) 0.803
Mean pressure of sensor 3 (Kg/cm2) 0.81 (0.24) 0.78 (0.28) 0.804
Mean Pressure of sensor 8 (Kg/cm2) 0.62 (0.24) 0.60 (0.16) 0.856
Data are means (SD). ∗ P<0.05 is considered significantly different
Table 6.6: Selected features to distinguished patients with and without neuropathy in free test
Free Test
No Neuropathy Neuropathy p∗
Initial activation time of sensor 1 (ms) 110.15 (53.19) 183.47 (87.26) 0.015
Initial activation time of sensor 5 (ms) 198.57 (97.87) 250.70 (136.54) 0.279
Mean Pressure of sensor 4 (Kg/cm2) 0.91 (0.33) 0.87 (0.29) 0.728
Mean pressure of sensor 6 (Kg/cm2) 0.32 (0.19) 0.25 (0.16) 0.375
Data are means (SD). ∗ P<0.05 is considered significantly different
Figure 6.2: Placement of the sensors with significantly different activation time comparing DPN
and NDPN patients from dataset 1
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6.2 Dataset 2
Dataset 2 allowed the acquisition of plantar pressure and accelerometer data. However, none DPN
patients were analysed. Therefore, as referred in subsection 5.1.1.2, the diabetes patients were
divided based on disease duration - lower and higher than 20 years.
One of the first steps taken to extract features from this dataset was split the accelerometer
data into steps based on information extracted from the Walkinsense. Figure 6.3 illustrates one
example of this accelerometer data division. Red and green lines represent the initial and final
time of each step, respectively. As mentioned in subsection 5.1.2.2, it was expected to find a peak
with high magnitude in the beginning of each step. However, figure 6.3 shows a slight shift in the
step detection, which can be due to the fact that the implemented algorithm to detect the first step
in the accelerometer data was based on a fixed threshold.
Figure 6.3: Accelerometer data divide into gait cycle. Red and green lines represent the initial and
final time of each step, respectively.
Table 6.7 summarizes the clinical details of the subjects and the obtained machine learning
results. No significantly differences were found in age and BMI for the tested groups.
The performance of both classifiers were similar, specially differentiating disease durations.
Nevertheless, again, it is expected that the increase size of the data leads to a better behaviour of
the SVM classifier comparing to kNN. In both classifications, the best accuracy obtained was high
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(96%). However, the number of subjects tested was small. Therefore, additional validation on a
larger number of subjects is need.
Tables 6.8 and 6.9 sum up the features selected to perform the two classifications. Statistical
analysis was only performed in features extracted from the Walkinsense data.
Table 6.8 shows that, to identify the presence of diabetes, most of the features were selected
from the Walkinsense. However, when the purpose was differentiate disease durations, table 6.9
shows that the number of selected features extracted from the accelerometer data increased, sug-
gesting that the accelerometer data could be more crucial distinguishing diabetes durations than
identify the presence of diabetes.
Additionally, the walking velocity of diabetes patients was significantly slower than healthy
subjects (table 6.8). Yavuzer et al. [8] suggested that this behaviour may be a compensatory
strategy adopted to improve stability or maintain the balance.
Moreover, the initial activation time of sensor 2 was significantly lower in diabetes patients
than in healthy subjects (Table 6.8 and figure 6.4a). On the other hand, the initial activation
time of sensor 7 was significantly higher in diabetes patients comparing with healthy subjects.
The sensor 7 and 2 were placed on the lateral side of the heel and on the pulp of the 1st finger,
respectively (figure 6.4a). Hereupon, based on the normal walking pattern, it was expected that the
sensor 7 was one of the first sensors to be activated and the sensor 2 the last sensor to be activated.
Therefore, these results suggest that the presence of diabetes can lead to an abnormal pressure
distribution during each step. In other words, a normal gait cycle starts with the contact of the
heel on the ground and the pressures are gradually distributed along the foot, finishing with the
contact of the toe (as illustrated in figure 5.3). Consequently, these results suggest that the diabetes
patients cannot perform a gradually distribution of the pressures along the foot. This hypothesis
is also supported by the statistical analysis of the features that were also extracted, but were not
selected by the FS algorithm to perform the classification (appendix A, table A.2). This statistical
analysis have shown that the initial activation time of a significant number of sensors were lower
in diabetes patients than in healthy subjects. On the other hand, the final activation time and the
activation time were higher in diabetes patients.
This hypothesis of a non-gradual distribution of pressures during the steps in diabetes patients
can explain the increased plantar pressures also encountered in this group (table 6.8, table A.2,
and figure 6.4b).
Table 6.9 shows that the initial activation time of sensors 1, 2, 5, and 6 were significantly higher
in diabetes patients with disease duration higher than 20 years, indicating that the sensors activated
before these sensors (placed on the rearfoot area) could have a higher activation time (figure 6.5a).
Hereupon, these results suggests an imbalance pressure distribution between the rearfoot and the
forefoot area in diabetes patients with higher disease duration. Caselli et al. [13] have shown
that forefoot/rearfoot pressures ratio is increased only in severe diabetic neuropathy, indicating an
imbalance in pressure distribution with increasing degrees of neuropathy. This hypothesis is also
supported by the significant differences found in plantar pressures of the sensors placed on the
rearfoot area (table 6.9 and figure 6.5b).
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Table 6.7: Clinical details of the subjects and machine learning results for the database 2
No Diabetes Diabetes Disease duration < 20 years Disease duration > 20 years
n (number of steps) 5 (120) 7 (265) 4 (129) 3 (136)
Age 73.20±5.07 76.43±3.36 77.25±3.78 75.33±3.06
BMI (Kgm2) 22.75±2.64 27.59±4.63 26.77±6.39 28.62±0.38
Diabetes Duration NA 21.57±14.6 11.75+±2.22 34.66±13.50†
SVM+FS (%) 91.18±4.02 96.21±3.82
kNN+FS (%) (k-value) 96.62±2.35 (11) 96.64±4.21 (25)
Data are means ± SD. NA - Non Applicable.∗ P<0.05vs No Diabetes group. † P<0.05vs No Neuropathy group
Table 6.8: Features selected to distinguished healthy subjects and diabetes patients
No Diabetes Diabetes p∗
Gait cycle velocity (m/s) 1.43(0.63) 0.92(0.39) 0.000
Initial activation time of sensor 2 (ms) 344.25 (156.13) 159.09 (125.47) 0.000
Initial activation time of sensor 7 (ms) 1.25 (4.01) 4.08 (15.33) 0.005
Activation time of sensor 6 (ms) 342 (161) 694 (1424) 0.007
Mean Pressure of sensor 3 (Kg/cm2) 0.79 (0.33) 0.98 (0.28) 0.000
Mean Pressure of sensor 6 (Kg/cm2) 0.23 (0.20) 0.41 (0.21) 0.000
Mean Pressure of sensor 7 1.26 (0.42) 1.40 (0.42) 0.003
Energy NA NA NA
Data are means (SD). NA -Non-Applicable ∗ P<0.05 is considered significantly different
(a) (b)
Figure 6.4: Placement of the sensors with significantly different activation time (a) and plantar
pressures (b) in healthy subjects and diabetes patients from dataset 2
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Table 6.9: Selected features to distinguished disease duration < 20 years and disease duration > 20
years
Disease duration < 20 years Disease duration > 20 years p∗
Initial activation time of sensor 1 (ms) 133.49 (65.02) 213.97 (135.68) 0.000
Initial activation time of sensor 2 (ms) 122.64 (106.22) 193.68 (132.70) 0.000
Initial activation time of sensor 5 (ms) 77.98 (37.51) 155.37 (155.14) 0.000
Initial activation time of sensor 6 (ms) 100.93 (65.45) 143.97 (120.91) 0.000
Final activation time of sensor 2 (ms) 848.37 (362.30) 1137.06 (1970.1) 0.103
Final activation time of sensor 5 (ms) 797.83 (335.34) 1089.26 (1871.19) 0.083
Final activation time of sensor 8 (ms) 668.22 (357.07) 936.91 (1981.37) 0.130
Activation time of sensor 1 (ms) 680.62 (345.83) 860.59 (1976.22) 0.309
Activation time of sensor 2 (ms) 725.74 (390.02) 943.38 (1978.92) 0.221
Mean Pressure of sensor 7 (Kg/cm2) 1.43 (0.42) 1.19(0.28) 0.000
Mean Pressure of sensor 8 (Kg/cm2) 1.31 (0.51) 1.48 (0.30) 0.001
Variance NA NA NA
Energy NA NA NA
Entropy NA NA NA
Minimum NA NA NA
4th order cumulant NA NA NA
Data are means (SD). NA -Non-Applicable ∗ P<0.05 is considered significantly different
(a) (b)
Figure 6.5: Placement of the sensors with significantly different activation time (a) and plantar
pressures (b) in diabetes patients with disease duration lower and higher than 20 years from dataset
2
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The statistical analysis (appendix A, table A.3) performed in the features that were not chosen
by the FS algorithm have shown that the initial activation time of sensor 3 and 4 (placed on the
forefoot area) were also higher in diabetes patients with a higher disease duration. On the other
hand, the initial activation time of sensor 8 (placed on rearfoot area) were lower in diabetes pa-
tients with lower disease duration. These results obtained from statistical analysis also support the
hypothesis that a long-term diabetes leads to an imbalance pressure distribution between forefoot
and rearfoot areas.
Chapter 7
Conclusions and Future Work
With reference on previous studies, plantar pressure sensors and smartphones built-in accelerom-
eters were used to collect gait data in order to identify signs of DPN.
Features were extracted and selected from signals, which allowed the training of a classifiers
to learn, based on these metrics, how to differentiate the different groups of interest. Machine
learning techniques were used to identify gait patterns. Two datasets were tested.
Ideally, it would be necessary use both accelerometers and plantar pressure sensors to collect
data from healthy subjects, NDPN, and DPN patients. However, none of the analysed datasets met
these desirable requirements.
In dataset 1, features were extracted only from plantar pressure sensors and two tests were
performed - conditioned and free tests. The results have shown that the better performances were
obtained when the subject walked freely, without the examination of any physician/doctor.
In dataset 2, accelerometers and plantar pressure sensors collected the gait data. However,
none of the diabetes patients were diagnosed with neuropathy. Therefore, the diabetes patients
were split based on disease durations - lower and higher than 20 years. This division were cho-
sen once the prevalence of neuropathy increases with the duration of diabetes. Hereupon, it is
expected that the results obtained from this division are similar to the ones encountered if the
presence/absence of neuropathy was evaluated.
In both datasets, the kNN classifier presented a more accurate performance than SVM. Notwith-
standing, since SVM is a more complex and less influenced by dimensionally problems, it is ex-
pected that these classifiers behaviour will be the opposite with the increase of the size of the
dataset.
The best accuracies achieved, in dataset 1, to identify the presence of diabetes and neuropa-
thy were 80.50% and 90%, respectively. Moreover, in dataset 2, the best obtained performances
were 96% for the both classifications (identify the presence of diabetes and differentiate disease
durations). Hereupon, these results have shown that higher accuracies were obtained in dataset 1,
suggesting that the both use of accelerometers and plantar pressure sensors is important to charac-
terize the gait of diabetes and DPN patients. The obtained accuracies suggest that the implemented
methodology may be used as a preliminary strategy in order to monitor and prevent DPN. How-
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ever, it is important to mention that the dimension of dataset 2 was lower, which could influence
these results.
In all the evaluations, features related with the distribution and duration of plantar pressure
were selected to perform the classification, supporting the hypothesis that the plantar pressures, as
well, as the duration of foot-floor contact time are crucial to identify the presence of diabetes and
DPN stages.
Additionally, statistical analysis have suggested that the diabetes and the long-term disease
could lead to a non-gradual and a imbalance plantar pressure distribution, respectively. Notwith-
standing, in a future work, the velocity should be taken in consideration during the results inter-
pretation.
7.1 Future work
Further development of this project would be of interest to increase the accuracy of the identifica-
tion of DPN and to better understand the effects of this disease in the walking patterns. The main
improvements of this project and future work were identified and will be explained in detail.
• The performance of various classification methods still depend greatly on the general char-
acteristics of the data to be classified. The obtained rate of classification was high but needs
additional validation on a larger number of subjects.
• One of the characteristics that could affected the performance of the classifiers was the
unbalance data. Therefore, in order to solve this problem, two main approaches can be
implemented: preprocess the data, or modify the standard classification algorithm to account
for class imbalance [68].
• Based on the obtained results, in the collection of a further dataset, the subjects should walk
freely and the data should be collect with plantar pressure sensors and accelerometer data.
• The division of the accelerometer data into gait cycle should be more accurate. Conse-
quently, evaluation of techniques to detect gait cycles from accelerometer data should be
performed.
• Since statistical analysis have suggested a non-gradual and a imbalance plantar pressure
distribution in diabetes patients. In feature extraction step, the sensors from the forefoot and
rearfoot areas should be grouped.
• Evaluate symmetries, analysing, separately, features from the left and right foot.
• In order to group the all the information obtained from the plantar pressure sensors, it can
be interest, in a future work, determine a dynamic center of pressure.
• In literature, diabetes also have been associated with reduction in range of motion in dif-
ferent joints, which was included among the main causes that lead to critical changes in
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walking pattern. Thus, in further work, features that could describe the range of motion
should be extracted.
• Evaluate other suitable devices to collect plantar pressures and accelerometer data. For
instances, Physilog system is an wearable standalone measurement unit containing inertial
sensors, that allows the extraction of gait parameters, widely validated, even for pathological
gait [74, 75, 76, 77].
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Appendix A
Statistical Analysis Results
As mention in section 3.5, feature selection methodology were implemented in order to select the
more relevant and informative feature to perform the classification.
Despite this selection, statistical analysis were implemented in all the extracted features. This
appendix summarizes the features where significant differences were found, despite these metrics
have not been selected by the FS algorithm.
Table A.1: Feature with significant differences extracted from dataset 1 in free test
Free Test
No Diabetes Diabetes No Neuropathy Neuropathy
Final time of activation of sensor 2 (ms) 659.97 (70.83) 605.31(85.15)∗ NA NA
Mean pressure of sensor 2 (Kg/cm2) NA NA 0.17 (0.087) 0.29 (0.19)†
Data are means (SD). NA - Non Applicable. ∗ P<0.05vs No Diabetes group. † P<0.05vs No Neuropathy group
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Table A.2: Feature with significant differences comparing healthy subjects and diabetes patients.
Features extracted from dataset 2
No Diabetes Diabetes
Mean Pressure of sensor 5 0.64 (0.27) 0.77 (0.34)∗
Mean Pressure of sensor 8(Kg/cm2) 1.26 (0.42) 1.40 (0.42)∗
Maximum of Maximal pressure(Kg/cm2) 3.02 (1.11) 2.72 (0.61)∗
Activation time of sensor 1 464.58 (198.63) 772.98 (1436.40)∗
Activation time of sensor 2 417.08 (184.22) 837.43 (1445.06)∗
Activation time of sensor 5 582.25 (163.91) 829.70 (1360.99)∗
Activation time of sensor 7 505.83 (111.133) 794.23 (1437.22)∗
Activation time of sensor 8 517.58 (113.31) 802.45 (1444.86)∗
Initial activation time of sensor 1 281.08 (146.08) 174.79 (114.40)∗
Initial activation time of sensor 3 188.00 (104.049) 96.11 (60.91)∗
Initial activation time of sensor 4 118.83 (50.93) 95.25 (109.38)∗
Initial activation time of sensor 5 154.25 (113.73) 117.70 (120.38)∗
Initial activation time of sensor 6 206.58 (147.68) 123.02 (99.70)∗
Final activation time of sensor 2 761.33 (121.89) 996.53 (1438.51)∗
Final activation time of sensor 6 548.58 (122.023) 817.66 (1430.51)∗
Final activation time of sensor 7 507.08 (110.87) 798.30 (1439.02)∗
Final activation time of sensor 8 522.08 (112.593) 806.11 (1444.80)∗
Stride length 1.095 (0.43) 0.791 (0.29)∗
Data are means (SD). ∗ P<0.05 vs No diabetes group
Table A.3: Feature with significant differences comparing different disease duration in diabetes
patients. Features extracted from dataset 2
Disease duration < 20 years Disease duration > 20 years
gait cycle velocity (m/s) 0.98 (0.34) 0.85 (0.41) ∗
Initial activation time of sensor 3 (ms) 85.89 (25.517) 105.81 (79.64)∗
Initial activation time of sensor 4 (ms) 68.22 (27.739) 120.88 (145.97)∗
Initial activation time of sensor 8 (ms) 5.58 (10.451) 1.84 (4.423)∗
Mean Pressure of sensor 3 (Kg/cm2) 1.08 (0.22) 0.88 (0.29)∗
Mean Pressure of sensor 4 (Kg/cm2) 1.20 (0.28) 1.03 (0.46)∗
Mean Pressure of sensor 5 (Kg/cm2) 0.87 (0.30) 0.68 (0.35)∗
Mean Pressure of sensor 6 (Kg/cm2) 0.37 (0.17) 0.43 (0.24)∗
Maximum of Maximal pressure (Kg/cm2) 2.62 (0.44) 2.81 (0.73)∗
Data are means (SD). ∗ P<0.05 vs Disease duration < 20 years group
